Raltegravir switch improves hepatitis C transaminitis in HIV-1 and hepatitis C (HCV) co-infected individuals

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1742-4690

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Raltegravir switch improves hepatitis C transaminitis in HIV-1 and hepatitis C (HCV) co-infected individuals ; volume:9 ; number:1 ; day:25 ; month:5 ; year:2012 ; pages:1 ; date:12.2012
Retrovirology ; 9, Heft 1 (25.5.2012), 1, 12.2012

Creator: Cevik, Muge

Contributor: Singh, Gurmit
Dickinson, Laura
Scourfield, Andrew
Boffito, Marta
Nelson, Mark
SpringerLink (Online service)

DOI: 10.1186/1742-4690-9-S1-O7

URN: urn:nbn:de:1111-2016080723601

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:01 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Cevik, Muge
Singh, Gurmit
Dickinson, Laura
Scourfield, Andrew
Boffito, Marta
Nelson, Mark
SpringerLink (Online service)

Other Objects (12)

Hepatitis C treatment initiation in HIV-HCV coinfected patients

Recurrent paratyphoid fever A co-infected with hepatitis A reactivated chronic hepatitis B

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

Substitution of tenofovir for nucleoside analogues in virologically controlled HIV-infected patients co-infected with hepatitis C virus: TEN-SWITCH

Hepatitis B vaccine efficacy in HCV vertical infected infants

Impact of hyperglycemia and cholesterol levels on the outcome of hepatitis C treatment in HIV/HCV co-infected patients

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012–2014)

Transmission networks of hepatitis C virus among HIV/HCV-coinfected patients in Guangdong, China

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users

MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Hepatitis C treatment initiation in HIV-HCV coinfected patients

Recurrent paratyphoid fever A co-infected with hepatitis A reactivated chronic hepatitis B

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

Substitution of tenofovir for nucleoside analogues in virologically controlled HIV-infected patients co-infected with hepatitis C virus: TEN-SWITCH

Hepatitis B vaccine efficacy in HCV vertical infected infants

Impact of hyperglycemia and cholesterol levels on the outcome of hepatitis C treatment in HIV/HCV co-infected patients

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012–2014)

Transmission networks of hepatitis C virus among HIV/HCV-coinfected patients in Guangdong, China

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users

MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Hepatitis C treatment initiation in HIV-HCV coinfected patients

Recurrent paratyphoid fever A co-infected with hepatitis A reactivated chronic hepatitis B

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

Substitution of tenofovir for nucleoside analogues in virologically controlled HIV-infected patients co-infected with hepatitis C virus: TEN-SWITCH

Hepatitis B vaccine efficacy in HCV vertical infected infants

Impact of hyperglycemia and cholesterol levels on the outcome of hepatitis C treatment in HIV/HCV co-infected patients

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012–2014)

Transmission networks of hepatitis C virus among HIV/HCV-coinfected patients in Guangdong, China

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users

MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Raltegravir switch improves hepatitis C transaminitis in HIV-1 and hepatitis C (HCV) co-infected individuals

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Hepatitis C treatment initiation in HIV-HCV coinfected patients

Recurrent paratyphoid fever A co-infected with hepatitis A reactivated chronic hepatitis B

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

Substitution of tenofovir for nucleoside analogues in virologically controlled HIV-infected patients co-infected with hepatitis C virus: TEN-SWITCH

Hepatitis B vaccine efficacy in HCV vertical infected infants

Impact of hyperglycemia and cholesterol levels on the outcome of hepatitis C treatment in HIV/HCV co-infected patients

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012–2014)

Transmission networks of hepatitis C virus among HIV/HCV-coinfected patients in Guangdong, China

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users

MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Hepatitis C treatment initiation in HIV-HCV coinfected patients

Recurrent paratyphoid fever A co-infected with hepatitis A reactivated chronic hepatitis B

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

Substitution of tenofovir for nucleoside analogues in virologically controlled HIV-infected patients co-infected with hepatitis C virus: TEN-SWITCH

Hepatitis B vaccine efficacy in HCV vertical infected infants

Impact of hyperglycemia and cholesterol levels on the outcome of hepatitis C treatment in HIV/HCV co-infected patients

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012–2014)

Transmission networks of hepatitis C virus among HIV/HCV-coinfected patients in Guangdong, China

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users

MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Hepatitis C treatment initiation in HIV-HCV coinfected patients

Recurrent paratyphoid fever A co-infected with hepatitis A reactivated chronic hepatitis B

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

Substitution of tenofovir for nucleoside analogues in virologically controlled HIV-infected patients co-infected with hepatitis C virus: TEN-SWITCH

Hepatitis B vaccine efficacy in HCV vertical infected infants

Impact of hyperglycemia and cholesterol levels on the outcome of hepatitis C treatment in HIV/HCV co-infected patients

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012–2014)

Transmission networks of hepatitis C virus among HIV/HCV-coinfected patients in Guangdong, China

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users

MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Related objects

Reset password